Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  871 results for ""Verteporfin""

Your Filters

Subject : photosensitizing agents
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Functional and anatomical results of subthreshold micropulse laser as rescue treatment for central serous chorioretinopathy after verteporfin shortage.

  • Authors : Oribio-Quinto C; Department of Ophthalmology, Fundación para la investigación biomédica Hospital Clínico San Carlos (IdISCC), Madrid, Spain. Electronic address: .; Alarcón-Garcia AD

Subjects: Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/surgery ; Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/drug therapy ; Verteporfin*/Verteporfin*/Verteporfin*/therapeutic use

  • Source: Photodiagnosis and photodynamic therapy [Photodiagnosis Photodyn Ther] 2024 Oct; Vol. 49, pp. 104295. Date of Electronic Publication: 2024 Jul 25.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101226123 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Infographic: Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: the ANCHOR study.

  • Authors : Yusuf IH; Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, Oxford University, West Wing, John Radcliffe Hospital, Oxford, OX3 9DU, UK. .; Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Headley Way, Oxford, OX3 9DU, UK. .

Subjects: Ranibizumab*/Ranibizumab*/Ranibizumab*/therapeutic use ; Ranibizumab*/Ranibizumab*/Ranibizumab*/administration & dosage ; Photochemotherapy*/Photochemotherapy*/Photochemotherapy*/methods

  • Source: Eye (London, England) [Eye (Lond)] 2024 Aug; Vol. 38 (Suppl 2), pp. 39-40. Date of Electronic Publication: 2023 Apr 24.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

One-year choroidal thickness changes after photodynamic therapy for central serous chorioretinopathy evaluated by widefield optical coherence tomography.

  • Authors : Sawaguchi S; Department of Ophthalmology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara-cho, Nakagami-gun, Okinawa, 903-0215, Japan.; Terao N

Subjects: Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/drug therapy ; Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/diagnosis ; Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/physiopathology

  • Source: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2024 Dec; Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 8205248 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Photodynamic therapy with verteporfin accelerates apoptotic bleb formation in human ameloblastoma.

  • Authors : Yamashita J; Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.; Kimoto A

Subjects: Verteporfin*/Verteporfin*/Verteporfin*/therapeutic use ; Photochemotherapy*/Photochemotherapy*/Photochemotherapy*/methods ; Photosensitizing Agents*/Photosensitizing Agents*/Photosensitizing Agents*/therapeutic use

  • Source: Oral diseases [Oral Dis] 2024 Jul; Vol. 30 (5), pp. 3261-3271. Date of Electronic Publication: 2023 Oct 27.Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9508565 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1601-0825

Record details

Read More Add to Saved list
×
Academic Journal

A Physiochemical, In Vitro, and In Vivo Comparative Analysis of Verteporfin-Lipid Conjugate Formulations: Solid Lipid Nanoparticles and Liposomes.

  • Authors : Shah N; Department of Bioengineering, University of Texas at Dallas, Richardson, Texas 75080, United States.; Soma SR

Subjects: Liposomes*/Liposomes*/Liposomes*/chemistry ; Nanoparticles*/Nanoparticles*/Nanoparticles*/chemistry ; Verteporfin*/Verteporfin*/Verteporfin*/chemistry

  • Source: ACS applied bio materials [ACS Appl Bio Mater] 2024 Jul 15; Vol. 7 (7), pp. 4427-4441. Date of Electronic Publication: 2024 Jun 27.Publisher: ACS Publications Country of Publication: United States NLM ID: 101729147 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Combination of Molecule-Targeted Therapy and Photodynamic Therapy Using Nanoformulated Verteporfin for Effective Uveal Melanoma Treatment.

  • Authors : Song M; Department of Ophthalmology, The Second Hospital of Jilin University, Changchun 130000, Jilin Province, China.; Zhu L

Subjects: Verteporfin*/Verteporfin*/Verteporfin*/pharmacology ; Verteporfin*/Verteporfin*/Verteporfin*/therapeutic use ; Photochemotherapy*/Photochemotherapy*/Photochemotherapy*/methods Uveal melanoma

  • Source: Molecular pharmaceutics [Mol Pharm] 2024 May 06; Vol. 21 (5), pp. 2340-2350. Date of Electronic Publication: 2024 Mar 28.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Carrier-Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery.

  • Authors : Quinlan JA; Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA.; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.

Subjects: Photochemotherapy*/Photochemotherapy*/Photochemotherapy*/methods ; Verteporfin*/Verteporfin*/Verteporfin*/pharmacology ; Verteporfin*/Verteporfin*/Verteporfin*/therapeutic use

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 May; Vol. 11 (17), pp. e2302872. Date of Electronic Publication: 2024 Mar 06.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

Read More Add to Saved list
×
Academic Journal

Combined photodynamic therapy and transpupillary thermotherapy for small choroidal melanoma.

  • Authors : Rolfe OJ; Queensland Ocular Oncology Service, Terrace Eye Centre, Brisbane, QLD, Australia. Electronic address: .; Stark AL

Subjects: Choroid Neoplasms*/Choroid Neoplasms*/Choroid Neoplasms*/therapy ; Choroid Neoplasms*/Choroid Neoplasms*/Choroid Neoplasms*/diagnosis ; Hyperthermia, Induced*/Hyperthermia, Induced*/Hyperthermia, Induced*/methods

  • Source: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie [Can J Ophthalmol] 2024 Dec; Vol. 59 (6), pp. 409-416. Date of Electronic Publication: 2024 Feb 29.Publisher: Elsevier Country of Publication: England NLM ID: 0045312 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1715-3360

Record details

Read More Add to Saved list
×
Academic Journal

Three-year outcome of photodynamic therapy combined with VEGF inhibitor for pachychoroid neovasculopathy.

  • Authors : Nomura Y; Department of Ophthalmology, University of Tokyo School of Medicine, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.; Aoki S

Subjects: Photochemotherapy*/Photochemotherapy*/Photochemotherapy*/methods ; Visual Acuity* ; Tomography, Optical Coherence*/Tomography, Optical Coherence*/Tomography, Optical Coherence*/methods

  • Source: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2024 Oct; Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 8205248 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacokinetics-Based Safety Evaluation in Half-Dose Verteporfin Photodynamic Therapy.

  • Authors : Kim HM; Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.; Department of Ophthalmology, Konkuk University School of Medicine, Seoul, Republic of Korea.

Subjects: Verteporfin*/Verteporfin*/Verteporfin*/pharmacokinetics ; Verteporfin*/Verteporfin*/Verteporfin*/administration & dosage ; Photochemotherapy*/Photochemotherapy*/Photochemotherapy*/methods

  • Source: Ophthalmic research [Ophthalmic Res] 2024; Vol. 67 (1), pp. 594-599. Date of Electronic Publication: 2024 Sep 26.Publisher: Karger Country of Publication: Switzerland NLM ID: 0267442 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0259

Record details

Read More Add to Saved list
×
  • 1-10 of  871 results for ""Verteporfin""